Cargando…
Miglustat in Niemann-Pick disease type C patients: a review
OBJECTIVE: Niemann-Pick disease type C (NP-C) is a rare, autosomal recessive, neurodegenerative disease associated with a wide variety of progressive neurological manifestations. Miglustat is indicated for the treatment of progressive neurological manifestations in both adults and children. Since ap...
Autores principales: | Pineda, Mercè, Walterfang, Mark, Patterson, Marc C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094874/ https://www.ncbi.nlm.nih.gov/pubmed/30111334 http://dx.doi.org/10.1186/s13023-018-0844-0 |
Ejemplares similares
-
Dysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustat
por: Walterfang, Mark, et al.
Publicado: (2012) -
Longitudinal assessment of reflexive and volitional saccades in Niemann-Pick Type C disease during treatment with miglustat
por: Abel, Larry A., et al.
Publicado: (2015) -
New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat
por: Wraith, James E, et al.
Publicado: (2009) -
Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study
por: Patterson, Marc C, et al.
Publicado: (2015) -
Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry
por: Patterson, Marc C., et al.
Publicado: (2020)